Passage Bio (PASG) Stock Price
Passage Bio Price
The consensus 12-month price target for Passage Bio is 8.00 USD, about 75.8% above where the stock trades today. Of 9 analysts, 6 rate the stock a buy — an overall Buy consensus.
Passage Bio stock price
Passage Bio business model & stock analysis
Frequently asked questions about Passage Bio
Analysts currently set an average price target of 10.00 USD for the Passage Bio stock (median: 8.00 USD), implying +119.8 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Passage Bio stock: 6 recommend buying, 3 holding and 0 selling.
Converted at the current exchange rate, the Passage Bio share trades at 4.04 EUR (4.55 USD).
The Passage Bio share (PASG) is listed on 1 stock exchanges, including: NASDAQ (PASG).
The revenue cannot currently be calculated for Passage Bio.
The expected profit of Passage Bio is -36.06 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Passage Bio is currently -0.40. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Passage Bio stock.
The P/S cannot be calculated for Passage Bio currently.
The Eulerpool Quality Score for Passage Bio is 2/10.
The ISIN of Passage Bio is US7027122099. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Passage Bio is A2P0EQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Passage Bio is PASG. The ticker symbol is used to trade Passage Bio shares on the stock exchange.
Passage Bio stock
Passage Bio Peer Group
Passage Bio Ticker
All fundamentals and in-depth analysis of Passage Bio
Our stock analysis for Passage Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Passage Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.